EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Variability in intrinsic drug tolerance in Mycobacterium tuberculosis corresponds with phylogenetic lineage

Valerie F A March, Michaela Zwyer, Chloé Loiseau, Daniela Brites, Galo A Goig, Selim Bouaouina, Anna Doetsch, Miriam Reinhard, Sevda Kalkan, Sebastien Gagneux iD, Sonia Borrell iD

Antimicrobial Agents and Chemotherapy · 2025

DOI: 10.1128/aac.00996-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2025. Verfasst von Valerie F A March und 10 weiteren Autor:innen. Beteiligte Einrichtung: Swiss Tropical and Public Health Institute, Allschwil, Switzerland. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Antitubercular Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council, Swiss National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug tolerance allows bacteria to survive extended exposure to bactericidal drugs and is thought to play a role in drug resistance evolution. In Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB), multidrug-resistant TB outbreaks are frequently caused by strains belonging to two phylogenetic lineages of the human-adapted strains of the Mtb complex, namely, lineages (L) 2 and L4. We hypothesized that members of L2 and L4 are more intrinsically drug tolerant and, as such, more readily evolve drug resistance. To explore this, we devised a high-throughput in vitro assay to measure drug tolerance in Mtb. We selected a cohort of strains representative of the globally most frequent lineages, L1–L4. We measured tolerance to rifampicin and bedaquiline and found L3 and L4 strains to have higher tolerance compared to L1 and L2 strains. In addition, phylogenetically closely related strains exhibited similar levels of tolerance, suggesting that tolerance is heritable. Finally, we explored genes previously reported to be associated with tolerance in Mtb and found significant enrichment in mutations in genes involved in cell wall and cell processes, intermediary metabolism and respiration, as well as lipid metabolism in high-tolerance strains.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisAntitubercular AgentsPhylogenyDiarylquinolinesRifampinMicrobial Sensitivity TestsHumansDrug Resistance, Multiple, BacterialTuberculosis, Multidrug-ResistantMutationCell Wall

Stichwörter der Autor:innen

Mycobacterium tuberculosisbedaquilinedrug tolerancegenetic diversityrifampicin

Substanzen

Antitubercular AgentsDiarylquinolinesbedaquilineRifampin

Autor:innen und Institutionen

  • Swiss Tropical and Public Health Institute, Allschwil, Switzerland.
  • University of Basel, Basel, Switzerland.

ORCID-Profile: Sebastien Gagneux, Sonia Borrell

Förderung

  • European Research Council
  • Swiss National Science Foundation

Zitieren

APA

March, V. F. A., Zwyer, M., Loiseau, C., Brites, D., Goig, G. A., Bouaouina, S., Doetsch, A., Reinhard, M., Kalkan, S., Gagneux, S., & Borrell, S. (2025). Variability in intrinsic drug tolerance in Mycobacterium tuberculosis corresponds with phylogenetic lineage. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00996-25

Vancouver

March VFA, Zwyer M, Loiseau C, Brites D, Goig GA, Bouaouina S, et al. Variability in intrinsic drug tolerance in Mycobacterium tuberculosis corresponds with phylogenetic lineage. Antimicrobial Agents and Chemotherapy. 2025. doi:10.1128/aac.00996-25

BibTeX
@article{March2025,
  author = {March, Valerie F A and Zwyer, Michaela and Loiseau, Chloé and Brites, Daniela and Goig, Galo A and Bouaouina, Selim and Doetsch, Anna and Reinhard, Miriam and Kalkan, Sevda and Gagneux, Sebastien and Borrell, Sonia},
  title = {Variability in intrinsic drug tolerance in Mycobacterium tuberculosis corresponds with phylogenetic lineage},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2025},
  doi = {10.1128/aac.00996-25}
}
Kostenlos starten →